头颈癌1年费用的分析:价值导向干预的靶点
该研究回顾性分析了196例仅在本院治疗的头颈癌患者的1年费用,采用多变量回归识别与费用增加相关的临床因素。结果显示放疗、手术和化疗是最昂贵的组成部分,鼻咽亚部位、晚期分期、治疗性手术、化疗、放疗、需重返手术室的并发症、急诊就诊和住院均与费用增加相关。
要点
- 放疗、手术和化疗是头颈癌1年费用中最昂贵的组成部分。
- 鼻咽亚部位、晚期分期及治疗相关并发症与费用增加显著相关。
- 最高四分位患者占总费用的55%,提示费用集中。
核心结论
- 放疗是头颈癌1年费用中最昂贵的组成部分,其次是手术和化疗。
- 研究识别了与费用增加相关的主要临床因素,包括鼻咽亚部位、晚期分期、治疗性手术、化疗、放疗、需重返手术室的并发症、急诊就诊和住院。
研究设计与样本
- 回顾性综述,单学术机构,纳入196例连续的头颈癌患者,仅在本院治疗,分析1年费用。
主要发现
- 患者平均年龄59.6岁(SD,14.9),男性占64%,白人占70%,商业保险占46%。
- 最常见原发部位为口咽(25%,其中76% HPV阳性)、皮肤(19%)和甲状腺(17%)。
- 每患者总费用中位数为212,484美元(四分位距,78,630-475,823美元)。
临床怎么用
- 临床实践中可关注放疗、手术和化疗的费用控制,以及减少并发症、急诊和住院以降低费用。
局限性
- 单中心回顾性研究,费用数据可能受机构特定因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the dominant clinical factors associated with increased 1-year charges in treating head and neck cancer. STUDY DESIGN: Retrospective review. SETTING: Single academic institution. SUBJECTS AND METHODS: We retrospectively reviewed 1-year charges for 196 consecutive patients with head and neck cancer (HNC) who were treated exclusively at our institution. We analyzed charges by department as well as factors associated with increased charges per multivariable regression. RESULTS: The mean age was 59.6 years (SD, 14.9). Most of the population was male (64%), white (70%), and commercially insured (46%). The most common primary sites were the oropharynx (25%; 76%, HPV positive), skin (19%), and thyroid (17%). Eighty-three percent of total charges were due to standard-of-care treatment for HNC: surgery ($16 million), radiation therapy ($22 million), or chemotherapy ($11 million). The median total charge per patient was $212,484 (interquartile range, $78,630-$475,823). Multivariable regression demonstrated that the following were associated with increased charges: nasopharynx subsite ($250,929 [95% CI, $93,290-$408,569]; effect size in US dollars, P = .002), advanced stage (American Joint Committee on Cancer, seventh edition; $80,331 [$22,726-$137,936], P = .007), therapeutic surgery ($281,893 [$117,371-$446,415], P = .001), chemotherapy ($183,331 [$125,497-$241,165], P < .001), radiation ($203,397 [$143,454-$263,341], P < .001), surgical complication requiring return to the operating room ($147,247 [$37,240-$257,254], P = .009), emergency department visits ($89,050 [$23,811-$154,289], P = .008), and admissions ($140,894 [$82,895-$198,893], P < .001; constant, -$233,927 [-$410,790 to -$57,064]). The top quartile accrued 55% of the total charges. CONCLUSION: Radiation, followed by surgery and chemotherapy, were the most expensive components of HNC care. In this analysis, we identified the dominant clinical factors associated with increased charges.
引用
- Pang J, Crawford K, Faraji F, et al. An Analysis of 1-Year Charges for Head and Neck Cancer: Targets for Value-Based Interventions. Otolaryngol Head Neck Surg. 2020. PMID: 32450778. doi:10.1177/0194599820921401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。